Literature DB >> 16613837

Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells.

Christie M Sayes1, Rajeev Wahi, Preetha A Kurian, Yunping Liu, Jennifer L West, Kevin D Ausman, David B Warheit, Vicki L Colvin.   

Abstract

Nanocrystalline titanium dioxide (nano-TiO(2)) is an important material used in commerce today. When designed appropriately it can generate reactive species (RS) quite efficiently, particularly under ultraviolet (UV) illumination; this feature is exploited in applications ranging from self-cleaning glass to low-cost solar cells. In this study, we characterize the toxicity of this important class of nanomaterials under ambient (e.g., no significant light illumination) conditions in cell culture. Only at relatively high concentrations (100 microg/ml) of nanoscale titania did we observe cytotoxicity and inflammation; these cellular responses exhibited classic dose-response behavior, and the effects increased with time of exposure. The extent to which nanoscale titania affected cellular behavior was not dependent on sample surface area in this study; smaller nanoparticlulate materials had effects comparable to larger nanoparticle materials. What did correlate strongly to cytotoxicity, however, was the phase composition of the nanoscale titania. Anatase TiO(2), for example, was 100 times more toxic than an equivalent sample of rutile TiO(2). The most cytotoxic nanoparticle samples were also the most effective at generating reactive oxygen species; ex vivo RS species generation under UV illumination correlated well with the observed biological response. These data suggest that nano-TiO(2) samples optimized for RS production in photocatalysis are also more likely to generate damaging RS species in cell culture. The result highlights the important role that ex vivo measures of RS production can play in developing screens for cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16613837     DOI: 10.1093/toxsci/kfj197

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  130 in total

Review 1.  The importance of a validated standard methodology to define in vitro toxicity of nano-TiO2.

Authors:  Janez Valant; Ivo Iavicoli; Damjana Drobne
Journal:  Protoplasma       Date:  2011-09-20       Impact factor: 3.356

2.  Titanium dioxide nanoparticles in food and personal care products.

Authors:  Alex Weir; Paul Westerhoff; Lars Fabricius; Kiril Hristovski; Natalie von Goetz
Journal:  Environ Sci Technol       Date:  2012-02-08       Impact factor: 9.028

Review 3.  The new toxicology of sophisticated materials: nanotoxicology and beyond.

Authors:  Andrew D Maynard; David B Warheit; Martin A Philbert
Journal:  Toxicol Sci       Date:  2010-12-22       Impact factor: 4.849

Review 4.  Intracellular signal modulation by nanomaterials.

Authors:  Salik Hussain; Stavros Garantziotis; Fernando Rodrigues-Lima; Jean-Marie Dupret; Armelle Baeza-Squiban; Sonja Boland
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 5.  Pulmonary applications and toxicity of engineered nanoparticles.

Authors:  Jeffrey W Card; Darryl C Zeldin; James C Bonner; Earle R Nestmann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-18       Impact factor: 5.464

Review 6.  Understanding engineered nanomaterial skin interactions and the modulatory effects of ultraviolet radiation skin exposure.

Authors:  Samreen Jatana; Lisa A DeLouise
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-03

7.  Assessing the potential exposure risk and control for airborne titanium dioxide and carbon black nanoparticles in the workplace.

Authors:  Min-Pei Ling; Chia-Pin Chio; Wei-Chun Chou; Wei-Yu Chen; Nan-Hung Hsieh; Yi-Jun Lin; Chung-Min Liao
Journal:  Environ Sci Pollut Res Int       Date:  2011-01-28       Impact factor: 4.223

Review 8.  Do nanomedicines require novel safety assessments to ensure their safety for long-term human use?

Authors:  Peter Hoet; Barbara Legiest; Jorina Geys; Benoit Nemery
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Effects of titanium dioxide nanoparticles on the inhibition of cellular activity in human Tenon's fibroblasts under UVA exposure.

Authors:  Seung-Uk Lee; Ji-Eun Lee; Su-Jin Kim; Jong-Soo Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-04       Impact factor: 3.117

Review 10.  Titanium dioxide nanoparticles: a review of current toxicological data.

Authors:  Hongbo Shi; Ruth Magaye; Vincent Castranova; Jinshun Zhao
Journal:  Part Fibre Toxicol       Date:  2013-04-15       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.